Skip to main content

Table 1 Baseline demographic and clinical characteristics of E-CS and E-CPR patients

From: Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation

 

All

E-CS

E-CPR

Patients, n (%)

90 (100)

50 (55.6)

40 (44.4)

Age (years), mean (SD)

58.8 (15.8)

60.0 (16.0)

57.4 (15.6)

Gender

 Male, n (%)

64 (71.1)

34 (68.0)

30 (75.0)

 Female, n (%)

26 (28.9)

16 (32.0)

10 (25.0)

BMI, mean (SD)

30.7 (6.96)

29.1 (7.28)

32.9 (5.93)

Race

 White, n (%)

43 (47.8)

24 (48.0)

19 (47.5)

 Black, n (%)

16 (17.8)

9 (18.0)

7 (17.5)

 Asian, n (%)

13 (14.4)

8 (16.0)

5 (12.5)

 Other, n (%)

18 (20.0)

9 (18.0)

9 (22.5)

Transfers, n (%)

40 (44.4)

30 (60.0)

10 (25.0)

Dual MCS therapy (Impella, IABP)

34 (37.8)

25 (50.0)

9 (22.5)

Diabetes, n (%)

33 (36.7)

17 (34.0)

16 (40.0)

Hypertension, n (%)

59 (65.6)

31 (62.0)

28 (70.0)

Hyperlipidemia, n (%)

39 (43.3)

23 (46.0)

16 (40.0)

Congestive heart failure, n (%)

20 (22.2)

14 (28.0)

6 (15.0)

Peripheral vascular disease, n (%)

8 (8.9)

6 (12.0)

2 (5.0)

Coronary artery disease, n (%)

56 (62.2)

31 (62.0)

25 (62.5)

Chronic obstructive pulmonary disease, n (%)

7 (7.8)

4 (8.0)

3 (7.5)

CKD/ESRD, n (%)

12 (13.3)

9 (18.0)

3 (7.5)

Past myocardial infarction, n (%)

21 (23.3)

11 (22.0)

10 (25.0)

Past cerebrovascular accident, n (%)

10 (11.1)

8 (16.0)

2 (5.0)

Smoking, n (%)

22 (24.4)

11 (22.0)

11 (27.5)

Ventilator support, n (%)

69 (76.7)

35 (70.0)

34 (85.0)

AKI/ RF (prior to ECMO initiation), n (%)

12 (13.3)

10 (20.0)

2 (5.0)

  1. AKI acute kidney injury, BMI body mass index, CKD chronic kidney disease, ECMO extracorporeal membrane oxygenation, E-CPR extracorporeal cardiopulmonary resuscitation, E-CS venoarterial extracorporeal membrane oxygenation for cardiogenic shock, ESRD end-stage renal disease, IABP intra-aortic balloon pump, MCS mechanical circulatory support, RF renal failure, SD standard deviation